For research use only. Not for therapeutic Use.
Aldafermin（Cat No.:I042181）is a recombinant fusion protein designed to activate the farnesoid X receptor (FXR), a receptor involved in regulating bile acid synthesis and metabolism. By activating FXR, aldafermin helps to regulate liver function, reduce inflammation, and promote the clearance of bile acids, which can be beneficial in treating liver diseases. It is being studied for its potential to treat nonalcoholic steatohepatitis (NASH), a liver condition characterized by fat accumulation and inflammation, and other liver-related disorders. Clinical trials are evaluating its safety, efficacy, and potential to improve liver health and function.
| Catalog Number | I042181 |
| CAS Number | 1616639-03-2 |
| Purity | ≥95% |
